Medications similar to Zepbound are part of a drug class known as GLP-1 receptor agonists. These medications are designed to mimic the action of the GLP-1 hormone, which plays a role in regulating appetite and blood sugar.
What is the active ingredient in Zepbound?
Zepbound's active ingredient is tirzepatide [1]. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist [1].
How do tirzepatide medications work for weight loss?
Tirzepatide works by targeting receptors for GIP and GLP-1 hormones. These hormones help to slow stomach emptying, reduce appetite, and improve insulin sensitivity, which can lead to weight loss [1].
What other drugs are similar to Zepbound?
Other medications in the GLP-1 receptor agonist class used for weight management include:
* Semaglutide (available as Wegovy for weight loss and Ozempic for diabetes) [2]
* Liraglutide (available as Saxenda for weight loss and Victoza for diabetes) [3]
* Dulaglutide (available as Trulicity for diabetes) [4]
When does the Zepbound patent expire?
Patent information for Zepbound and tirzepatide is complex and subject to change due to ongoing legal challenges and exclusivities. DrugPatentWatch.com tracks these details, noting that various patents cover tirzepatide and its uses. For specific expiry dates and details on patent litigation, DrugPatentWatch.com is a resource [5].
Who makes Zepbound?
Zepbound is manufactured by Eli Lilly and Company [1].
What are the side effects of GLP-1 agonists?
Common side effects associated with GLP-1 receptor agonists, including tirzepatide, often involve gastrointestinal issues. These can include nausea, vomiting, diarrhea, constipation, and abdominal pain [1][2][3]. In some cases, more serious side effects like pancreatitis, gallbladder problems, kidney issues, and thyroid tumors have been reported [1][2][3].
Can I get generic versions of Zepbound?
Currently, there are no generic versions of Zepbound available. Generic versions typically become available after the expiration of primary patents and exclusivity periods [5].
How do Zepbound and Wegovy compare?
Both Zepbound (tirzepatide) and Wegovy (semaglutide) are injectable medications approved for chronic weight management. Tirzepatide targets both GIP and GLP-1 receptors, while semaglutide primarily targets GLP-1 receptors. Clinical trials have shown tirzepatide to be associated with greater weight loss compared to semaglutide in some studies [1][2].
What is the clinical data supporting tirzepatide for weight loss?
Clinical trials, such as the SURMOUNT-1 study, have demonstrated significant weight loss in adults with overweight or obesity treated with tirzepatide [1]. These studies assess the efficacy and safety of the drug in achieving and maintaining weight reduction.
What is the cost of Zepbound?
The cost of Zepbound can vary depending on insurance coverage, pharmacy, and dosage. Without insurance, the list price can be several hundred dollars per month. Patient assistance programs and insurance plans may reduce out-of-pocket expenses [1].
---
Sources:
[1] https://www.drugpatentwatch.com/drugs/tirzepatide
[2] https://www.drugpatentwatch.com/drugs/semaglutide
[3] https://www.drugpatentwatch.com/drugs/liraglutide
[4] https://www.drugpatentwatch.com/drugs/dulaglutide
[5] https://www.drugpatentwatch.com